Expertise in
1
conditions

Paul F. Griffin

Raymond Terrace, 
Brisbane, QLD, AU 
Expertise in
1
conditions
Raymond Terrace, 
Brisbane, QLD, AU 

Overview

Paul Griffin practices practicing medicine in Brisbane, Australia.

Mr. Griffin is highly rated in 1 condition, according to our data. His clinical expertise encompasses Congenital Syphilis, Severe Acute Respiratory Syndrome (SARS), Malaria, and Situs Inversus.

He is actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

Raymond Terrace, Brisbane, QLD, Australia
Other Locations
288 Herston Road, Herston, QLD 4006, Australia
Level 3, Aubigny Place, Raymond Terrace, South Brisbane, QLD 4101, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Double Blind, Placebo Controlled, Multicenter, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of HTD1801 in Adults With Hypercholesterolemia
A Randomized, Double Blind, Placebo Controlled, Multicenter, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of HTD1801 in Adults With Hypercholesterolemia
Enrollment Status: Completed
Publish Date: August 11, 2026
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-APOC3 in Adult Healthy Volunteers as Well as in Severely Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome
A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-APOC3 in Adult Healthy Volunteers as Well as in Severely Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome
Enrollment Status: Completed
Publish Date: December 24, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Dosage-Escalation, Single Centre Study to Evaluate the Safety and Immunogenicity of an Adjuvanted SARS-CoV-2 Sclamp Protein Subunit Vaccine in Healthy Adults Aged 18 to 55 Years Old and Healthy Older Adults, Aged 56 Years and Over
A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Dosage-Escalation, Single Centre Study to Evaluate the Safety and Immunogenicity of an Adjuvanted SARS-CoV-2 Sclamp Protein Subunit Vaccine in Healthy Adults Aged 18 to 55 Years Old and Healthy Older Adults, Aged 56 Years and Over
Enrollment Status: Completed
Publish Date: May 02, 2024
Intervention Type: Biological, Other
Study Drugs: COVID-19 Sclamp Vaccine, MF59 Adjuvant
Study Phase: Phase 1
A 2-Part, Phase 1/2, Randomized, Observer-Blinded Study To Evaluate The Safety And Immunogenicity Of A SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Or Without MATRIX-M™ Adjuvant In Healthy Subjects
A 2-Part, Phase 1/2, Randomized, Observer-Blinded Study To Evaluate The Safety And Immunogenicity Of A SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Or Without MATRIX-M™ Adjuvant In Healthy Subjects
Enrollment Status: Completed
Publish Date: April 10, 2023
Intervention Type: Biological, Other
Study Phase: Phase 1/Phase 2
A Randomized, Placebo-controlled, Single-Ascending Dose Phase Ia Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
A Randomized, Placebo-controlled, Single-Ascending Dose Phase Ia Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
Enrollment Status: Completed
Publish Date: April 07, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Immunogenicity of the bacTRL-Spike Oral Candidate Vaccine for the Prevention of COVID-19 in Healthy Adults
A Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Immunogenicity of the bacTRL-Spike Oral Candidate Vaccine for the Prevention of COVID-19 in Healthy Adults
Enrollment Status: Completed
Publish Date: October 25, 2022
Intervention Type: Biological
Study Drug: bacTRL-Spike Vaccine
Study Phase: Phase 1
A Randomized, Double-blind, Crossover Study to Compare the Pharmacokinetic and Pharmacodynamic Bioequivalence of a Single Injection of MSB11455 and Neulasta in Healthy Adult Subjects
A Randomized, Double-blind, Crossover Study to Compare the Pharmacokinetic and Pharmacodynamic Bioequivalence of a Single Injection of MSB11455 and Neulasta in Healthy Adult Subjects
Enrollment Status: Completed
Publish Date: July 02, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Five Part Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetic (PK) Profile of Single and Repeat Oral Doses of FDL176 in Healthy and Cystic Fibrosis (CF) Participants
A Five Part Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetic (PK) Profile of Single and Repeat Oral Doses of FDL176 in Healthy and Cystic Fibrosis (CF) Participants
Enrollment Status: Completed
Publish Date: September 06, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

77 Total Publications

Fresnel zone plates for reconfigurable atomic waveguides.
Fresnel zone plates for reconfigurable atomic waveguides.
Journal: Optics express
Published: August 14, 2026

Frequently Asked Questions about Paul F. Griffin

Is Paul F. Griffin a top-rated expert for Congenital Syphilis?

MediFind is an objective health platform that identifies experts based on real-world data. Paul F. Griffin is classified as an Advanced expert for Congenital Syphilis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Paul F. Griffin participate in research or clinical trials?

Yes. Paul F. Griffin has published 77 articles and abstracts on conditions like Congenital Syphilis. You can view a list of Paul F. Griffin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Griffin's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile